Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
FSR and ATS are pleased to welcome joint new hire John Matthew “Matt” Craig, PhD.
-
Dublin, April 23, 2026 (GLOBE NEWSWIRE) -- The "Renal Tubular Acidosis Market - A Global and Regional Analysis: Focus on Country and Regional Analysis, 2025-2035" report has been added to ...
-
Dublin, April 23, 2026 (GLOBE NEWSWIRE) -- The "Tuberous Sclerosis Complex Market - A Global and Regional Analysis: Focus on Country and Regional Analysis, 2025-2035" report has been added to ...
-
Soleo Health launches SoleoRare™, a dedicated rare disease specialty pharmacy delivering clinician-led, patient-centered care for rare disease patients.
-
PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique Le dépôt du dossier réglementaire pour l’initiation de l’essai clinique de Phase 2a évaluant son candidat...
-
PannTheraPi files Phase 2a trial for epilepsy drug PTI5803, secures EU patent, and appoints Sophie Binay as GM & CSO.
-
Dublin, April 13, 2026 (GLOBE NEWSWIRE) -- The "Small Molecule Innovator API CDMO Market Size, Share & Trends Analysis Report by Stage Type, Customer Type, Therapeutic Area, Region, and Segment...
-
Veld Pharmaceuticals, announced a collaboration with Chiesi Farmaceutici S.p.A in Africa for Rare Disease Therapies
-
FRISCO, Texas and AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the opening of...
-
Agios will report its first quarter 2026 financial results and business highlights on Wednesday, April 29, 2026.